Chinese Journal of Dermatology ›› 2021, Vol. 54 ›› Issue (7): 597-604.doi: 10.35541/cjd.20200576
• Original Articles • Previous Articles Next Articles
Liu Junlin1, Wang Wei2, Cao Zhirui1, Liu Kun1, Wan Duoyan1, Wu Zhiming3, Luo Yang1, Xiao Chuanliu1, Liu Lu4, Yin Mei5
Received:
2020-06-10
Revised:
2021-01-30
Online:
2021-07-15
Published:
2021-07-02
Contact:
Liu Lu; Yin Mei
E-mail:liulu8887@163.com; liujunlin0759@163.com
Supported by:
Liu Junlin, Wang Wei, Cao Zhirui, Liu Kun, Wan Duoyan, Wu Zhiming, Luo Yang, Xiao Chuanliu, Liu Lu, Yin Mei. Analysis of relationship between psoriasis vulgaris and vitamin D receptor gene in a Han population in Hainan Province based on targeted capture sequencing[J]. Chinese Journal of Dermatology, 2021, 54(7): 597-604.doi:10.35541/cjd.20200576
[1] | Nagpal S, Lu J, Boehm MF. Vitamin D analogs: mechanism of action and therapeutic applications[J]. Curr Med Chem, 2001,8(13):1661⁃1679. doi: 10.2174/0929867013371950. |
[2] | Kontula K, Välimäki S, Kainulainen K, et al. Vitamin D receptor polymorphism and treatment of psoriasis with calcipotriol[J]. Br J Dermatol, 1997,136(6):977⁃978. doi: 10.1111/j.1365⁃2133. 1997.tb03955.x. |
[3] | Lee DY, Park BS, Choi KH, et al. Vitamin D receptor genotypes are not associated with clinical response to calcipotriol in Korean psoriasis patients[J]. Arch Dermatol Res, 2002,294(1⁃2):1⁃5. doi: 10.1007/s00403⁃002⁃0293⁃3. |
[4] | Zhou X, Xu LD, Li YZ. The association of polymorphisms of the vitamin D receptor gene with psoriasis in the Han population of northeastern China[J]. J Dermatol Sci, 2014,73(1):63⁃66. doi: 10.1016/j.jdermsci.2013.08.014. |
[5] | Rucevic I, Stefanic M, Tokic S, et al. Lack of association of vitamin D receptor gene 3′⁃haplotypes with psoriasis in Croatian patients[J]. J Dermatol, 2012,39(1):58⁃62. doi: 10.1111/j.1346⁃8138.2011.01296.x. |
[6] | Acikbas I, Sanlı B, Tepeli E, et al. Vitamin D receptor gene polymorphisms and haplotypes (Apa I, Bsm I, Fok I, Taq I) in Turkish psoriasis patients[J]. Med Sci Monit, 2012,18(11):CR661⁃666. doi: 10.12659/msm.883544. |
[7] | Polić MV, Rucević I, Barisić⁃Drusko V, et al. Polymorphisms of vitamin D receptor gene in the population of eastern Croatia with psoriasis vulgaris and diabetes mellitus[J]. Coll Antropol, 2012,36(2):451⁃457. |
[8] | 刘军麟, 曾慧明, 林岷格, 等. 维生素D受体基因多态性与寻常性银屑病易感性及卡泊三醇疗效的相关性[J]. 中华皮肤科杂志, 2017,50(12):889⁃893. doi: 10.3760/cma.j.issn.0412⁃4030.2017.12.007. |
[9] | 赵辨. 中国临床皮肤病学[M]. 2版. 南京: 江苏科学技术出版社, 2017. |
[10] | Reichrath J, Zouboulis CC, Vogt T, et al. Targeting the vitamin D endocrine system (VDES) for the management of inflammatory and malignant skin diseases: An historical view and outlook[J]. Rev Endocr Metab Disord, 2016,17(3):405⁃417. doi: 10.1007/s11154⁃016⁃9353⁃4. |
[11] | Bouillon R, Carmeliet G, Verlinden L, et al. Vitamin D and human health: lessons from vitamin D receptor null mice[J]. Endocr Rev, 2008,29(6):726⁃776. doi: 10.1210/er.2008⁃0004. |
[12] | Wang TT, Tavera⁃Mendoza LE, Laperriere D, et al. Large⁃scale in silico and microarray⁃based identification of direct 1,25⁃dihydroxyvitamin D3 target genes[J]. Mol Endocrinol, 2005,19(11):2685⁃2695. doi: 10.1210/me.2005⁃0106. |
[13] | Kovalenko PL, Zhang Z, Cui M, et al. 1,25 Dihydroxyvitamin D⁃mediated orchestration of anticancer, transcript⁃level effects in the immortalized, non⁃transformed prostate epithelial cell line, RWPE1[J]. BMC Genomics, 2010,11:26. doi: 10.1186/1471⁃2164⁃11⁃26. |
[14] | Gombart AF. The vitamin D⁃antimicrobial peptide pathway and its role in protection against infection[J]. Future Microbiol, 2009,4(9):1151⁃1165. doi: 10.2217/fmb.09.87. |
[15] | Verstuyf A, Carmeliet G, Bouillon R, et al. Vitamin D: a pleiotropic hormone[J]. Kidney Int, 2010,78(2):140⁃145. doi: 10.1038/ki.2010.17. |
[16] | Hansen CM, Binderup L, Hamberg KJ, et al. Vitamin D and cancer: effects of 1,25(OH)2D3 and its analogs on growth control and tumorigenesis[J]. Front Biosci, 2001,6:D820⁃848. doi: 10.2741/hansen. |
[17] | Janmaat VT, Van De Winkel A, Peppelenbosch MP, et al. Vitamin D receptor polymorphisms are associated with reduced esophageal vitamin D receptor expression and reduced esophageal adenocarcinoma risk[J]. Mol Med, 2015,21:346⁃354. doi: 10.2119/molmed.2012.00336. |
[18] | Orlow I, Reiner AS, Thomas NE, et al. Vitamin D receptor polymorphisms and survival in patients with cutaneous melanoma: a population⁃based study[J]. Carcinogenesis, 2016,37(1):30⁃38. doi: 10.1093/carcin/bgv157. |
[19] | de Azevêdo Silva J, Monteiro Fernandes K, Trés Pancotto JA, et al. Vitamin D receptor (VDR) gene polymorphisms and susceptibility to systemic lupus erythematosus clinical manifestations[J]. Lupus, 2013,22(11):1110⁃1117. doi: 10.1177/ 0961203313500549. |
[20] | Cavalcanti CA, Silva Jde A, Pita Wde B, et al. Vitamin D receptor polymorphisms and expression profile in rheumatoid arthritis Brazilian patients[J]. Mol Biol Rep, 2016,43(1):41⁃51. doi: 10.1007/s11033⁃015⁃3937⁃z. |
[21] | Oh JJ, Byun SS, Lee SE, et al. Genetic variations in VDR associated with prostate cancer risk and progression in a Korean population[J]. Gene, 2014,533(1):86⁃93. doi: 10.1016/j.gene. 2013.09.119. |
[22] | Chang CK, Mulholland HG, Cantwell MM, et al. Vitamin D receptor gene variants and esophageal adenocarcinoma risk: a population⁃based case⁃control study[J]. J Gastrointest Cancer, 2012,43(3):512⁃517. doi: 10.1007/s12029⁃011⁃9322⁃9. |
[23] | Fang Y, Yu B, Yang Y, et al. Association between vitamin D receptor genetic polymorphisms and haplotypes and risk of lumbar degenerative disc disease in a Chinese population[J]. Int J Clin Exp Pathol, 2017,10(8):8695⁃8702. |
[24] | Vimaleswaran KS, Power C, Hyppönen E. Interaction between vitamin D receptor gene polymorphisms and 25⁃hydroxyvitamin D concentrations on metabolic and cardiovascular disease outcomes[J]. Diabetes Metab, 2014,40(5):386⁃389. doi: 10. 1016/j.diabet.2014.01.003. |
[25] | Shen F, Guo C, Wang Y, et al. Low serum 25⁃hydroxyvitamin D levels may increase the detrimental effect of VDR variants on the risk of essential hypertension[J]. Eur J Clin Nutr, 2020,74(7):1091⁃1099. doi: 10.1038/s41430⁃019⁃0543⁃5. |
[26] | Yu F, Wang C, Wang L, et al. Study and evaluation the impact of vitamin D receptor variants on the risk of type 2 diabetes mellitus in Han Chinese[J]. J Diabetes, 2017,9(3):275⁃284. doi: 10.1111/1753⁃0407.12413. |
[27] | Karami S, Brennan P, Rosenberg PS, et al. Analysis of SNPs and haplotypes in vitamin D pathway genes and renal cancer risk[J/OL]. PLoS One, 2009,4(9):e7013. https://journals.plos.org/plosone/ article?id=10.1371/journal.pone.0007013. doi: 10.1371/journal.pone.0007013. |
[28] | Hu Q, Chen Z, Liang G, et al. Vitamin D receptor gene associations with pulmonary tuberculosis in a Tibetan Chinese population[J]. BMC Infect Dis, 2016,16:469. doi: 10.1186/s12879⁃016⁃1699⁃4. |
[29] | Kelly JL, Drake MT, Fredericksen ZS, et al. Early life sun exposure, vitamin D⁃related gene variants, and risk of non⁃Hodgkin lymphoma[J]. Cancer Causes Control, 2012,23(7):1017⁃1029. doi: 10.1007/s10552⁃012⁃9967⁃0. |
[30] | Jurutka PW, Remus LS, Whitfield GK, et al. The polymorphic N terminus in human vitamin D receptor isoforms influences transcriptional activity by modulating interaction with transcription factor IIB[J]. Mol Endocrinol, 2000,14(3):401⁃420. doi: 10.1210/mend.14.3.0435. |
[31] | Colin EM, Weel AE, Uitterlinden AG, et al. Consequences of vitamin D receptor gene polymorphisms for growth inhibition of cultured human peripheral blood mononuclear cells by 1, 25⁃dihydroxyvitamin D3[J]. Clin Endocrinol (Oxf), 2000,52(2):211⁃216. doi: 10.1046/j.1365⁃2265.2000.00909.x. |
[32] | Holt SK, Kwon EM, Koopmeiners JS, et al. Vitamin D pathway gene variants and prostate cancer prognosis[J]. Prostate, 2010,70(13):1448⁃1460. doi: 10.1002/pros.21180. |
[33] | Shi J, Grundy A, Richardson H, et al. Genetic variation in vitamin D⁃related genes and risk of breast cancer among women of European and East Asian descent[J]. Tumour Biol, 2016,37(5):6379⁃6387. doi: 10.1007/s13277⁃015⁃4417⁃8. |
[34] | Jingwi EY, Abbas M, Ricks⁃Santi L, et al. Vitamin D receptor genetic polymorphisms are associated with PSA level, gleason score and prostate cancer risk in African⁃American men[J]. Anticancer Research, 2015, 35(3):1549⁃1558. |
[1] | Writing committee expert group on “diagnosis and treatment of pustular psoriasis: a Chinese expert consensus statement”. Diagnosis and treatment of pustular psoriasis: a Chinese expert consensus statement (2022) [J]. Chinese Journal of Dermatology, 2022, 55(3): 187-195. |
[2] | Wang Xiaowen, Li Ruoyu. Superficial fungal infections in psoriasis patients treated with IL-17 related biological agents and their management [J]. Chinese Journal of Dermatology, 2022, 55(3): 272-275. |
[3] | Wang Yue, Yan Yulin. Analysis of adverse drug reactions and reasons for drug discontinuation during acitretin therapy in 171 patients with psoriasis vulgaris [J]. Chinese Journal of Dermatology, 2022, 55(3): 242-245. |
[4] | Li Yan, Li Ming, Xu Wei, Li Linfeng. Efficacy of fluticasone propionate cream alone or in combination with calcipotriol ointment in the treatment of mild to moderate plaque psoriasis: a randomized self-controlled study [J]. Chinese Journal of Dermatology, 2022, 55(3): 260-263. |
[5] | Wang Zhaoyang, Chen Anwei, Xiang Xin, Luo Xiaoyan, Xu Zigang, Wang Hua, Ma Lin. An investigation into the current situation of pediatric psoriasis based on the information systems from two children′s hospitals [J]. Chinese Journal of Dermatology, 2022, 55(3): 246-250. |
[6] | Zhang Tingting, Zhu Fengyi, Yang Mei, Zhang Ping, Xia Ping, Zhou Xiaoyong. Clinical efficacy and safety of secukinumab in the treatment of 7 cases of erythrodermic psoriasis [J]. Chinese Journal of Dermatology, 2022, 0(2): 20210644-e20210644. |
[7] | Ou Min, Yan Yunling, Zheng Baoqing, Wang Xiaohua. Correlations between psoriasis and obesity [J]. Chinese Journal of Dermatology, 2022, 55(2): 181-184. |
[8] | Gao Rong, Zhang Lan, Li Zhengxiao. Biological agents in the treatment of moderate to severe plaque psoriasis and psoriatic arthritis [J]. Chinese Journal of Dermatology, 2022, 55(1): 72-75. |
[9] | Lu Jiawei, Lu Yan. Paradoxical psoriasis induced by tumor necrosis factor-α inhibitors and other biological agents [J]. Chinese Journal of Dermatology, 2022, 0(1): 20210420-e20210420. |
[10] | Zhao Ying, Wang Juanjuan, Ji Jiang, Su Wenxing, Wei Yuqian, Leng Hong, Ding Yujie, Shi Xin. Interleukin-17A-mediated psoriasis and cardiovascular comorbidities [J]. Chinese Journal of Dermatology, 2022, 55(1): 76-79. |
[11] | Lin Luyang, Chen Zhengliang, Zhang Xibao. Major immune-related cells in psoriasis vulgaris lesions [J]. Chinese Journal of Dermatology, 2021, 54(9): 830-834. |
[12] | Lan Xiaoou, Wang Qiang, Li Shangyun, Sun Xiaodong, Song Danyang, Li Jiawei, Song Guoqiang, Hu Lanting, Geng Long. Topical shikonin: intervention effect on an imiquimod-induced psoriasis-like mouse model and influence on CEBPD expression [J]. Chinese Journal of Dermatology, 2021, 54(8): 696-701. |
[13] | Yu Yingyuan, Li Ying, Yu Zengyang, Zheng Jianfeng, Zhang Xilin, Ding Yangfeng, Shi Yuling, . Efficacy and safety of infliximab in the treatment of severe plaque psoriasis and its effect on the expression of programmed cell death-1 and programmed cell death ligand-1 [J]. Chinese Journal of Dermatology, 2021, 54(7): 590-596. |
[14] | Committee on Psoriasis, Chinese Society of Dermatology, Committee on Children, Chinese Society of Dermatology. Consensus on the diagnosis and treatment of childhood psoriasis in China (2021) [J]. Chinese Journal of Dermatology, 2021, 54(7): 559-581. |
[15] | Ying Jieya, Xiang Wenzhong, Song Xiuzu. Metabolic syndrome and skin diseases [J]. Chinese Journal of Dermatology, 2021, 54(7): 642-645. |
|